COMMUNIQUÉS West-GlobeNewswire

CloudMD Receives Court Approval of Proposed Transaction with CPS Capital
03/07/2024
TORONTO, July 03, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, Frankfurt: 6PH) (the “ Company ” or “ CloudMD ”), an innovative health services company transforming the delivery of care, is [...]
OPTIMAS Now Available from The Peer Group
03/07/2024
Give Your Skin a More Youthful, Revitalized Appearance with Breakthrough Radiofrequency Microneedling Skin Treatments from The Northern New Jersey Team FLORHAM PARK, N.J., July 03, 2024 (GLOBE NEWSWIRE) -- The Peer [...]
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/07/2024
CAMBRIDGE, Mass., July 03, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare [...]
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/07/2024
SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to [...]
Sharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery
03/07/2024
Swiss-based provider of cosmetic, dental, and ophthalmic injectable therapies issues purchase orders for 1mL SecureGard ultra-low waste, smart safety syringes First 100k unit shipment is scheduled for late July, with [...]
Monthly information related to total number of voting rights and shares composing the share capital – July 1, 2024
03/07/2024
Article 223-16 of general regulation of French Autorité des Marchés Financiers Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com Date Total of shares [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 1er juillet 2024
03/07/2024
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation : Euronext Paris (Compartiment C - Code ISIN : FR001400K4B1 – Symbole : PHXM) Site web : www.phaxiam.com Date Nombre total d’ [...]
Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371
03/07/2024
Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371 Ingelheim, Germany and Nantes, France, 3 July 2024 – Today Boehringer Ingelheim [...]
OSE Immunotherapeutics et Boehringer Ingelheim poursuivent l’avancée du développement clinique du traitement first-in-class SIRPα BI 770371 en immunologie du cancer
03/07/2024
OSE Immunotherapeutics et Boehringer Ingelheim poursuivent l’avancée du développement clinique du traitement first-in-class SIRPα BI 770371 en immunologie du cancer Nantes, France et Ingelheim, Allemagne – le 3 juillet [...]
IVI RMA Global and Lavima Fertility join forces in research in fertility treatments
03/07/2024
VALENCIA, Spain and BRUSSELS, July 03, 2024 (GLOBE NEWSWIRE) -- Seeking alternatives to obtain oocytes without ovarian stimulation is a pioneering line of research in reproductive medicine. The inconveniences that the [...]
Eurobio Scientific : bilan semestriel du contrat de liquidité
03/07/2024
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE Paris, le 3 juillet 2024 –17h45 Au titre du contrat de liquidité portant sur les actions de la société EUROBIO SCIENTIFIC (FR0013240934 – ALERS FP) confié à TP ICAP (Europe), les [...]
Sharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024
03/07/2024
All shareholders of record as of May 17, 2024 are eligible to vote Final votes must be cast by 11:59 p.m., Eastern Time on July 12, 2024 NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS [...]
Appeal launched to support people impacted by Hurricane Beryl
03/07/2024
OTTAWA, July 03, 2024 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the Hurricane Beryl Appeal to help those affected by the hurricane. The Red Cross is working to help those impacted by Hurricane Beryl in the [...]
Lancement d’un fonds de secours en réponse à l’ouragan Béryl
03/07/2024
OTTAWA, 03 juill. 2024 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne a mis sur pied le Fonds de secours : Ouragan Béryl afin de venir en aide aux personnes touchées par la catastrophe. La Croix-Rouge s’emploie à [...]
Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care
03/07/2024
Sheridan, Wyoming, USA, July 03, 2024 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - Rafarma Pharmaceuticals is pleased to announce the signing of a preliminary agreement to establish a joint industrial [...]
Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium
03/07/2024
Multiple studies confirm ART12.11’s superior advantages as a product candidate for the treatment of anxiety related disorders SOLANA BEACH, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: [...]
Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment
03/07/2024
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses preliminary positive results from the first five “lead-in” patients in the Company’s ongoing human clinical trial THE WOODLANDS, TX , July 03, 2024 ( [...]
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
03/07/2024
OCALA, Fla., July 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the next CEO Corner segment has been published on the Company’s website. For the CEO [...]
The International Myeloma Foundation Thanks Dr. Brian G.M. Durie for 35 Years of Remarkable Leadership
03/07/2024
Assembles Global Dream Team and Establishes Scientific Advisory Board to Accelerate Myeloma Research STUDIO CITY, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that [...]

Pages